Fig. 3From: The effect of temperature on the stability of PCSK-9 monoclonal antibody: an experimental studyPercent change in inhibition from baseline to 9 and 18 h in each study condition: a alirocumab 3.75 mg/ml, b evolocumab 7 mg/mlBack to article page